x

Cerca un progetto di ricerca

* (*) campo obbligatorio

27 Risultato/i

Ordinato per

Finanziato da un ente associato a IRDiRC =

Progetti di ricerca

AUSTRIA

WIEN
WIEN

Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Chirurgie

FINLANDIA

Finland
HELSINKI

Finanziato da un ente associato a IRDiRCIdiopathic pulmonary fibrosis (IPF) -Development of therapeutic applications
University of Helsinki
Institute of Clinical Medicine

FRANCIA

BOURGOGNE-FRANCHE-COMTE
DIJON

Finanziato da un ente associato a IRDiRCSHOT-IPF: Small HSPs Inhibitors to Treat Idiopathic Pulmonary Fibrosis - FR
CHU Dijon Bourgogne - Hôpital François Mitterrand
Service de Pneumologie - Soins Intensifs, Appareillage Respiratoire

FRANCIA

CENTRE-VAL DE LOIRE
TOURS

Finanziato da un ente associato a IRDiRCAcoustic Waves and Helium/oxygen for Aerosol Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Faculté de Médecine, Université de Tours François Rabelais
Équipe Inserm 3 : « Aérosolthérapie et biothérapies à visée respiratoire »

FRANCIA

ILE-DE-FRANCE
PARIS

Finanziato da un ente associato a IRDiRCProtease-activated Receptor-2 and its agonist serine proteases in idiopathic pulmonary fibrosis
Faculté de Médecine Paris Diderot Paris 7 - site Bichat
Physiopathologie et épidémiologie des maladies respiratoires (Inserm UMR 1152)

FRANCIA

ILE-DE-FRANCE
PARIS

Finanziato da un ente associato a IRDiRCFibroPRX : PRRX (Paired Related Homeobox Protein)-1 as a novel and key transcription factor in lung fibrosis: in search for innovative targets
Faculté de Médecine Paris Diderot Paris 7 - site Bichat
Physiopathologie et épidémiologie des maladies respiratoires (Inserm UMR 1152)

GERMANIA

Hessen
GIEßEN

Clinical research team "lung fibrosis" : Pathogenetic role and therapeutic benefit of the pulmonal surfactant system in fibrotic lung diseases
Med. Klinik und Poliklinik II des UKGM am Standort Gießen
Schwerpunkt Pneumologie und Intensivmedizin - Fibrosierende Lungenerkrankungen

IRLANDA

County Dublin
DUBLIN

ITALIA

LOMBARDIA
MONZA

Valutazione dello stato nutrizionale nella fibrosi polmonare idiopatica: uno studio pilota
Azienda Ospedaliera San Gerardo
Dipartimento Cardio-Toraco-Vascolare

PAESI BASSI

Utrecht
NIEUWEGEIN

Genetic predisposition to interstitital lung diseases and disease phenotypes
St. Antonius Ziekenhuis, locatie Nieuwegein
Longcentrum

SPAGNA

Baleares
PALMA DE MALLORCA

Finanziato da un ente associato a IRDiRCRole of MSCs in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and analysis of their reparative / antiinflammatory capacity in an experimental model of pulmonary fibrosis
IdISBa - Fundació Institut d'Investigació Sanitaria Illes Balears
Grupo de investigación en Inflamación, reparación y cáncer en enfermedades respiratorias

SPAGNA

Cataluña
SABADELL

Finanziato da un ente associato a IRDiRCThe pulmonary microbiome in idiopathic pulmonary fibrosis
Institut d'Investigació i Innovació Parc Taulí
Área de Inflamación, inmunología y metabolismo

SPAGNA

Madrid
MADRID

Study of telomere length in IPF patients as a tool to know the genetic bases and counseling advise in the disease
Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM)
Laboratorio de enfermedades teloméricas (Laboratorio de Rosario Perona Abellón)

GIAPPONE

JAPAN
ADDRESS : NOT PROVIDED - JP

Progetti di ricerca multicentrici